Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...It’s a step in the right direction but it doesn’t solve the whole problem,” Harrison said....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...The aborted trials include Pfizer and Johnson & Johnson’s scrapped study in 2012 and Merck’s failed trial in 2017....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Job moves Sanjay Kapoor has taken over as Google’s M&A chief from Don Harrison, who is now in a slightly different role....
...(FT) Japan Inc goes global for M&A advice Only three domestic brokerages rank among the top-ten deal advisers in Japan during the third quarter. Why is Japan Inc looking for foreign advice?...
...Known internally as “Area 120,” executives Don Harrison and Bradley Horowitz will reportedly manage the new scheme....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...But a relatively new boss who does so risks becoming a historical footnote, like William Henry Harrison....
...Sophie Harrison is a hospital doctor in South Yorkshire...
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Among the new generation of leaders of large pharmaceutical groups, which have increasingly spurned scientists in nominations in recent years, Jeff Kindler at Pfizer and Severin Schwan at Roche are also...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Imaginatik’s software and processes that engage staff across a company’s workforce in solving problems or innovating new products or systems have proved popular with large clients such as Pfizer, Dow Chemical...
...“Our competitors get into these brand wars like Coke v Pepsi,” says Zimmer at UTA....
...Andy Harrison, Easyjet chief executive, was able to boast late last year that his was one of the few European airlines to remain profitable over the previous 12 months....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...says Harrison. “We have to ask ourselves ‘what might this business be worth to someone else?’...
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition